SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-179839
Filing Date
2021-06-02
Accepted
2021-06-02 16:05:44
Documents
14
Period of Report
2021-05-27
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d184924d8k.htm   iXBRL 8-K 39654
2 EX-3.1 d184924dex31.htm EX-3.1 4984
3 EX-99.1 d184924dex991.htm EX-99.1 90485
  Complete submission text file 0001193125-21-179839.txt   296458

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cris-20210527.xsd EX-101.SCH 3092
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cris-20210527_lab.xml EX-101.LAB 19657
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cris-20210527_pre.xml EX-101.PRE 12329
7 EXTRACTED XBRL INSTANCE DOCUMENT d184924d8k_htm.xml XML 3724
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

IRS No.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30347 | Film No.: 21989117
SIC: 2836 Biological Products, (No Diagnostic Substances)